E4402 – Randomized Phase III Trial Comparing Two Different Rituximab Dosing Regimens for Patients with Low Tumor Burden Indolent non-Hodgkin’s Lymphoma

Physician and Research Staff Educational Materials:

  • None available

Patient Educational Materials:

  • Patient FAQs: frequently asked questions from patients about treatment, eligibility criteria, and potential enrollment issues, with answers in lay language.

Additional Information at ClinicalTrials.gov:

NCT00075946